Document is current
Any future updates will be listed below
-
Authors
Modi, Bhavi P.
Del Bel, Kate L.
Lin, Susan
Sharma, Mehul
Richmond, Phillip A.
van Karnebeek, Clara D. M.
Chan, Edmond S.
Avinashi, Vishal
Rehmus, Wingfield E.
Biggs, Catherine M.
Wasserman, Wyeth W.
Turvey, Stuart E. https://orcid.org/0000-0003-1599-1065
-
Funding
Funding for this research was provided by:
Genome British Columbia (SIP007)
- License Information
-
More Information
Article History
Received: 18 June 2020
Accepted: 4 January 2021
First Online: 14 January 2021
Ethics approval and consent to participate
: Research study protocols were approved by our institutional review board (H09-01228). Two members of the family (the affected child and his mother) were enrolled. Written informed consent for genetic testing and participation was provided by the mother for her child.
: Manuscript was shared with the family in advance of submission and legal guardian gave consent to proceed with publication.
: VA has been a member of the advisory board for AVIR Pharma. ESC has received research support from DBV Technologies, has been a member of advisory boards for Pfizer, Pediapharm, Leo Pharma, Kaleo, DBV, is a member of the healthcare advisory board for Food Allergy Canada, was an expert panel and coordinating committee member of the National Institute of Allergy and Infectious Diseases (NIAID)-sponsored Guidelines for Peanut Allergy Prevention, is co-lead of the CSACI oral immunotherapy guidelines, and is a member of the committee for the American Gastroenterological Association & AAAAI/ACAAI Joint Task Force guidelines on the management of eosinophilic esophagitis.
